PROSTATE CA
Clinical trials for PROSTATE CA explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CA trials appear
Sign up with your email to follow new studies for PROSTATE CA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to wipe out prostate cancer before surgery
Disease control Recruiting nowThis study is testing whether adding a drug called homoharringtonine to standard hormone therapy before prostate cancer surgery can better shrink or eliminate tumors. It will involve 96 men with locally advanced or limited metastatic prostate cancer. The goal is to see if this co…
Matched conditions: PROSTATE CA
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New combo therapy aims to shrink prostate cancer before surgery
Disease control Recruiting nowThis study is testing whether adding two new drugs (fasudil hydrochloride and a PD1 inhibitor) to standard hormone therapy before prostate cancer surgery works better than standard therapy alone. The goal is to see if this combination shrinks the cancer more effectively, potentia…
Matched conditions: PROSTATE CA
Phase: PHASE2, PHASE3 • Sponsor: baotai Liang • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Two-Drug attack on prostate cancer before surgery
Disease control Recruiting nowThis study is testing whether giving two hormone-blocking drugs (darolutamide and relugolix) before prostate removal surgery is safe and can shrink tumors in men with high-risk prostate cancer. The trial will enroll about 30 men to see if they can complete the drug treatment with…
Matched conditions: PROSTATE CA
Phase: PHASE1 • Sponsor: AdventHealth • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Two shots vs. five: race to find the best prostate cancer radiation
Disease control Recruiting nowThis study aims to find out if a very short course of radiation (2 treatments) is as good as the standard short course (5 treatments) for men with intermediate-risk prostate cancer. Researchers will compare side effects, quality of life, and cancer control between the two schedul…
Matched conditions: PROSTATE CA
Phase: PHASE2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New hope for men suffering from cancer treatment hot flashes
Symptom relief Recruiting nowThis study is testing a drug called fezolinetant to see if it can safely reduce hot flashes in men with prostate cancer who are receiving hormone-blocking therapy. The drug is already approved for hot flashes in women. Researchers will measure how well it reduces the frequency an…
Matched conditions: PROSTATE CA
Phase: PHASE2 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Apr 03, 2026 21:10 UTC